Vascular Health and Risk Management

Editor in Chief Professor Roland Asmar

Editorial: Risk of cardiovascular events and cyclooxygenase-2 inhibitors ||FREE PAPER||
Reza Tabrizchi

Clinical implications of angiogenesis in cancers
Roberta WC Pang, Ronnie TP Poon

Endovascular stent-graft placement for vascular failure of the thoracic aorta
Yoshihiko Kurimoto, Kiyofumi Morishita, Yasufumi Asai

A review of Perindopril in the reduction of cardiovascular events
Duncan J Campbell

Valsartan in the treatment of heart attack survivors
Bodh I Jugdutt

The use of metoprolol CR/XL in the treatment of patients with diabetes and chronic heart failure
Ovidio De Freitas, Oliver Lenz, Alessia Fornoni, Barry J Materson

Metabolic syndrome, inflammation and atherosclerosis
Rodolfo Paoletti, Chiara Bolego, Andrea Poli, Andrea Cignarella

Lipoprotein-associated phospholipase A2, vascular inflammation and cardiovascular risk prediction
Krishnankutty Sudhir

Plant sterols as dietary adjuvants in the reduction of cardiovascular risk: theory and evidence
Craig S Patch, Linda C Tapsell, Peter G Williams, Michelle Gordon

Leptin and hypertension in obesity
Paco E Bravo, Stephen Morse, David M Borne, Erwin A Aguilar, Efrain Reisin

Vascular risks and management of obesity in children and adolescents
Courtney J Jolliffe, Ian Janssen

Screening for popliteal aneurysms should not be a routine part of a community-based aneurysm screening program
Martin Claridge, Simon Hobbs, Clive Quick, Donald Adam, Andrew Bradbury, Teun Wilmink

Join ISVH
Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)
Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University